K. Bork

发表

Cutaneous Side Effects of Drugs

K. Bork, 1987 .

Long-standing pigmented keloid of the ears induced by electrical torture.

K. Bork, C. Nagel, Konrad Bork, 1997, Journal of the American Academy of Dermatology.

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

R. Lockey, R. Pawankar, W. Aberer, 2022, The World Allergy Organization journal.

The International/Canadian Hereditary Angioedema Guideline

P. Keith, J. Bernstein, H. Farkas, 2019, Allergy, Asthma & Clinical Immunology.

Canadian hereditary angioedema guideline

P. Keith, J. Bernstein, H. Farkas, 2014, Allergy, Asthma & Clinical Immunology.

WAO Guideline for the Management of Hereditary Angioedema

R. Lockey, R. Pawankar, W. Lumry, 2012, The World Allergy Organization journal.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

P. Keith, J. Bernstein, R. Schellenberg, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedema

K. Bork, P. Staubach, J. Hardt, 2008, Allergy.

Cutaneous Adverse Drug Reactions

K. Bork, 2009 .

Physical forces in blister formation. The role of colloid osmotic pressure and of total osmolality in fluid migration into the rising blister.

K. Bork, 1978, The Journal of investigative dermatology.

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

A. Tordai, L. Truedsson, M. López-Trascasa, 2004, Journal of Allergy and Clinical Immunology.

Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review.

T. Machnig, K. Bork, I. Steffensen, 2013, Allergy and asthma proceedings.

Impaired function of numerically augmented Fc-receptors on granulocytes in a HLA B8+ patient with palmoplantar pustulosis

K. Bork, R. Schopf, M. Rehder, 2004, Archives of Dermatological Research.

Autoantibody-mediated acquired deficiency of C1 inhibitor.

J. Alsenz, K. Bork, M. Loos, 1987, The New England journal of medicine.

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

M. Triggiani, W. Aberer, J. Bernstein, 2014, Allergy.

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

P. Schlattmann, J. Frank, K. Bork, 2007, The Journal of allergy and clinical immunology.

Guideline: Hereditary angioedema due to C1 inhibitor deficiency

T. Biedermann, K. Bork, E. Aygören‐Pürsün, 2019, Allergo Journal International.

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

William H. Yang, P. Keith, R. Schellenberg, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

William H. Yang, H. Farkas, R. Warrington, 2004, The Journal of allergy and clinical immunology.

Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema

K. Bork, G. Witzke, 2016, International Archives of Allergy and Immunology.

Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis

N. Brattig, K. Bork, G. Burchard, 2000, Tropical medicine & international health : TM & IH.

Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel.

M. Cicardi, K. Binkley, K. Bork, 2012, Allergy and asthma proceedings.

Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.

K. Bork, J. Hardt, G. Witzke, 2012, The Journal of allergy and clinical immunology.

Panniculitis due to potassium bromide

E. Becker, K. Bork, P. Berg, 1998, Brain and Development.

A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE)

K. Bork, 2016, Clinical Reviews in Allergy & Immunology.

Currently available treatments and future treatment options for hereditary angioedema

K. Bork, 2015, Allergo Journal International.

An evidence based therapeutic approach to hereditary and acquired angioedema

K. Bork, 2014, Current opinion in allergy and clinical immunology.

Current Management Options for Hereditary Angioedema

K. Bork, 2012, Current Allergy and Asthma Reports.

Hereditary angioedema with normal C1‐INH with versus without specific F12 gene mutations

K. Bork, K. Wulff, J. Hardt, 2015, Allergy.

Pruritus precipitated by hydroxyethyl starch: a review

K. Bork, Konrad Bork, 2005, The British journal of dermatology.

High exhaled nitric oxide levels correlate with nonadherence in acute asthmatic children

S. Boor, K. Bork, R. Brehler, 2017 .

Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency.

K. Bork, G. Witzke, Konrad Bork, 1989, The Journal of allergy and clinical immunology.

Increasing incidence of eczema herpeticum: analysis of seventy-five cases.

K. Bork, W. Bräuninger, Konrad Bork, 1988, Journal of the American Academy of Dermatology.

Stimulation of T lymphocytes by isolated autologous or allogeneic human epidermal cells

K. Bork, R. Schopf, B. Morsches, 1984 .

Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants

F. Marceau, J. Hébert, K. Binkley, 2020, Frontiers in Medicine.

[WAO Guideline for the Management of Hereditary Angioedema].

R. Lockey, R. Pawankar, W. Lumry, 2015, Arerugi = [Allergy].

A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor.

K. Bork, K. Wulff, P. Meinke, 2011, Clinical immunology.

Currently available treatments and future treatment options for hereditary angioedema

K. Bork, 2015, Allergo Journal.

New drug targets and future direction: icatibant

K. Bork, 2012 .

[Physical bases of blister formation. II. A study of the total osmotic pressure in the blister fluid of suction blisters and of "naturally" occurring blisters as well as in the serum].

K. Bork, 1978, Archives of dermatological research.

Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation.

Michael J. Wilson, S. Dower, S. Busfield, 2018, The Journal of allergy and clinical immunology.

[Massive upper gastrointestinal bleeding as first clinical manifestation of pseudoxanthoma elasticum (author's transl)].

M. Rothmund, K. Bork, H. Gabbert, 1980, Zeitschrift fur Gastroenterologie.

Hereditary angioedema: new findings concerning symptoms, affected organs, and course.

K. Bork, P. Staubach, J. Hardt, 2006, The American journal of medicine.

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update

R. Lockey, R. Pawankar, W. Lumry, 2018, Allergy.

Effects of ethanol and acetaldehyde on phagocytic functions

K. Bork, R. Schopf, M. Trompeter, 2004, Archives of Dermatological Research.

Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.

B. Wolf, K. Bork, A. Kaplan, 2016, The Journal of allergy and clinical immunology.

Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.

K. Bork, M. Davis-Lorton, 2013, European annals of allergy and clinical immunology.

Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

M. Triggiani, W. Aberer, R. Perricone, 2012, Allergy.

Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema.

K. Bork, S. Barnstedt, 2003, Journal of the American Dental Association.

Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency.

K. Bork, J. Hardt, K. Schicketanz, 2003, Archives of internal medicine.

Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema.

K. Bork, P. Koch, 2001, Journal of the American Academy of Dermatology.

Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema.

K. Bork, S. Barnstedt, Konrad Bork, 2001, Archives of internal medicine.

Hereditary angioedema with normal C1-inhibitor activity in women

K. Bork, H. Traupe, S. Barnstedt, 2000, The Lancet.

Asphyxiation by laryngeal edema in patients with hereditary angioedema.

K. Bork, W. Kreuz, R. Schopf, 2000, Mayo Clinic proceedings.

Hepatocellular adenomas in patients taking danazol for here ditary angiooedema

K. Bork, P. Harten, M. Pitton, 1999, The Lancet.

Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.

John D Lambris, J. Lambris, J. Alsenz, 1989, The Journal of clinical investigation.

Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study.

K. Bork, P. Staubach‐Renz, J. Hardt, 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Hereditary angioneurotic oedema and blood-coagulation: Interaction between C1-esterase-inhibitor and the activation factors of the proteolytic enzyme systems

K. Bork, P. Beneš, G. Witzke, 1983, Klinische Wochenschrift.

Sudden upper airway obstruction in patients with hereditary angioedema.

K. Bork, Nina Ressel, 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

HAE international home therapy consensus document

M. Gompels, H. Farkas, M. Levi, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2

K. Bork, D. Cohn, L. Fijen, 2021, Clinical Reviews in Allergy & Immunology.

Allergic contact dermatitis on a violinist's neck from para‐phenylenediamine in a chin rest stain

K. Bork, 1993, Contact dermatitis.

Primary plasmacytoma of the skin.

T. Tüting, K. Bork, Konrad Bork, 1996, Journal of the American Academy of Dermatology.

[Simulation of malignant tumors by undeclared polyvinylpyrrolidone in drugs].

K. Bork, N. Hoede, 1982, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Hereditary progressive mucinous histiocytosis in women. Report of three members in a family.

K. Bork, N. Hoede, Konrad Bork, 1988, Archives of dermatology.

ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

A. Dunant, J. Roujeau, M. Mockenhaupt, 2010, Clinical pharmacology and therapeutics.

Diseases of the Lips and Mouth

K. Bork, 2009 .

Stimulation of T cells by autologous mononuclear leukocytes and epidermal cells in psoriasis

K. Bork, R. Schopf, A. Hoffmann, 2004, Archives of Dermatological Research.

[Undifferentiated cutaneous angiosarcoma of the head: identification by the endothelial marker Ulex europaeus agglutinin I].

J. Fries, K. Bork, G. Korting, 1985, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Pathogenesis of paraneoplastic follicular hyperkeratotic spicules in multiple myeloma. Follicular and epidermal accumulation of IgG dysprotein and cryoglobulin.

K. Bork, J. Pfeifle, M. Böckers, 1990, Archives of dermatology.

[Does a circumscribed melanosis secondary to malignant melanoma exist?].

K. Bork, G. Korting, N. Hoede, 1977, Dermatologica.

Hereditary angioedema with a mutation in the plasminogen gene

I. Braenne, K. Bork, K. Wulff, 2018, Allergy.

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.

Tom Bowen, Erik Waage Nielsen, Hilary Longhurst, 2012, The Journal of allergy and clinical immunology.

Disease expression in women with hereditary angioedema.

H. Farkas, C. Bucher, M. Cicardi, 2008, American journal of obstetrics and gynecology.

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

M. Triggiani, P. Schmid‐Grendelmeier, W. Aberer, 2016, Allergy.

Acquired and hereditary forms of recurrent angioedema: Update of treatment

K. Bork, 2018, Allergologie select.

Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.

T. Machnig, J. Bernstein, T. Craig, 2015, Allergy and asthma proceedings.

Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.

K. Bork, 2014, Immunotherapy.

Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency

K. Bork, 2011, Expert review of clinical immunology.

Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions

K. Bork, 2008, Expert review of clinical immunology.

Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema

K. Bork, P. Staubach, J. Hardt, 2005, Transfusion.

Multifocal aplasia cutis congenita, distal limb hemimelia, and cutis marmorata telangiectatica in a patient with Adams–Oliver syndrome

K. Bork, J. Jfeifle, Konrad Bork, 1992, The British journal of dermatology.

[Flea bites caused by Archaeopsylla erinacei, the hedgehog flea].

K. Bork, N. Hoede, K. Honomichl, 1987, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[Prurigo and further diagnostically significant skin symptoms in strongyloidosis].

K. Bork, M. Böckers, 1988, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients.

K. Bork, A. Bygum, J. Hardt, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor.

K. Bork, G. Dewald, 2006, Biochemical and biophysical research communications.

Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.

T. Machnig, J. Bernstein, T. Craig, 2016, The Journal of emergency medicine.

Contributions EFFICACY OF DIFFERENT MEDICAL THERAPIES FOR THE TREATMENT OF ACUTE LARYNGEAL ATTACKS OF HEREDITARY ANGIOEDEMA DUE TO C 1-ESTERASE INHIBITOR DEFICIENCY

T. Machnig, J. Bernstein, T. Craig, 2022 .

Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations.

K. Bork, 2006, Immunology and allergy clinics of North America.

Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor.

K. Bork, A. Kaplan, Haixiang Jiang, 2021, Molecular immunology.

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

William H. Yang, P. Keith, P. Schmid‐Grendelmeier, 2010, The New England journal of medicine.

Economic costs associated with acute attacks and long-term management of hereditary angioedema.

K. Bork, A. Rentz, W. Pullman, 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema

P. Keith, T. Craig, S. Neri, 2013, International Archives of Allergy and Immunology.

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

William H. Yang, P. Keith, P. Kralickova, 2017, The New England journal of medicine.

Long‐term efficacy of danazol treatment in hereditary angioedema

H. Farkas, G. Füst, K. Bork, 2011, European journal of clinical investigation.

Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week

K. Bork, J. Hardt, 2010, International Archives of Allergy and Immunology.

Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.

H. Joller-jemelka, L. Truedsson, C. Hack, 2008, Journal of immunological methods.

Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries

R. Krüger, V. Wahn, W. Aberer, 2020, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Current drugs in early development for hereditary angioedema: potential for effective treatment

K. Bork, 2014, Expert opinion on investigational drugs.

Hereditary angioedema with normal C1 inhibitor.

K. Bork, 2013, Immunology and allergy clinics of North America.

Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor

K. Bork, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Diagnosis and treatment of hereditary angioedema with normal C 1 inhibitor

K. Bork, 2010 .

Hereditary angioedema with normal C1 inhibition

K. Bork, 2009, Current allergy and asthma reports.

Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.

K. Bork, K. Wulff, P. Staubach, 2009, The Journal of allergy and clinical immunology.

Hereditary angio‐oedema with normal C1 inhibitor in a family with affected women and men

K. Bork, G. Dewald, D. Gül, 2006, The British journal of dermatology.

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

H. Farkas, K. Bork, E. Aygören‐Pürsün, 2022, Allergy, Asthma & Clinical Immunology.

Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema

W. Aberer, W. Lumry, H. Farkas, 2021, Clinical Reviews in Allergy & Immunology.

Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report

T. Craig, K. Bork, H. Longhurst, 2021, Allergy, Asthma & Clinical Immunology.

Hereditary angioedema: an update on causes, manifestations and treatment.

K. Bork, H. Longhurst, 2019, British journal of hospital medicine.

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey

W. Aberer, B. Goichot, S. Kivity, 2017, Allergy, Asthma & Clinical Immunology.

Recurrent angioedema and the threat of asphyxiation.

K. Bork, 2010, Deutsches Arzteblatt international.

Symptoms, Course, and Complications of Abdominal Attacks in Hereditary Angioedema Due to C1 Inhibitor Deficiency

A. Eckardt, K. Bork, P. Staubach, 2006, The American Journal of Gastroenterology.

Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema.

K. Bork, V. Schneiders, 2002, Journal of hepatology.

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III.

S. Cichon, M. Nöthen, T. Renné, 2006, American journal of human genetics.

Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy.

K. Bork, G. Dewald, B. Fischer, 2003, The American journal of medicine.

Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema

J. Oldenburg, K. Bork, W. Kreuz, 2008, Cytogenetic and Genome Research.

Blindness, tetraspasticity, and other signs of irreversible brain damage in hereditary angioedema.

S. Boor, K. Bork, R. Brehler, 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

The Expanding Spectrum of Mutations in Hereditary Angioedema.

H. Farkas, K. Bork, B. Zuraw, 2021, The journal of allergy and clinical immunology. In practice.

Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor

H. Arcuri, M. Palma, N. Monnier, 2015, International Archives of Allergy and Immunology.

Kallikrein–kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys

K. Bork, J. Hardt, G. Witzke, 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course.

K. Bork, J. Hardt, G. Dewald, 2007, The American journal of medicine.

Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex.

K. Bork, G. Dewald, 2004, The American journal of medicine.

Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence

T. Machnig, K. Bork, K. Wulff, 2020, Orphanet Journal of Rare Diseases.

sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor.

M. Frank, K. Bork, A. Kaplan, 2020, Molecular immunology.

Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N‐terminal cleavage site of bradykinin

I. Braenne, H. Rossmann, K. Bork, 2019, Allergy.

A review of hereditary angioedema and recombinant human C1-inhibitor treatment

M. Triggiani, K. Bork, A. Relan, 2011 .

Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice

M. Triggiani, W. Aberer, B. Goichot, 2017, Allergy.

Abstracts from the 10th C1-inhibitor deficiency workshop

William H. Yang, A. Szilágyi, M. Margaglione, 2017, Allergy, Asthma & Clinical Immunology.

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey

K. Bork, J. Botha, E. Aygören‐Pürsün, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Hereditary angioedema: causes, manifestations and treatment.

K. Bork, H. Longhurst, 2006, British journal of hospital medicine.

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study

W. Aberer, B. Goichot, S. Kivity, 2018, Clinical and Translational Allergy.

A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family

E. Donadi, H. Arcuri, E. Castelli, 2011, Allergy.

Der Internist

Redaktion, K. Bork, E. Aygören‐Pürsün, 2019 .

Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema.

H. Farkas, G. Füst, C. Bucher, 2007, Helicobacter.

A systematic review of the efficacy and safety of a purified, pasteurized C1 inhibitor concentrate for the treatment of patients with type I or II hereditary angioedema

K. Bork, D. Barnes, A. Neme, 2010, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

Side Effects Of Long-Term Treatment With Danazol And Stanozolol In Hereditary Angioedema

H. Farkas, C. Bucher, M. Cicardi, 2007 .

Efficacy of C1-Inhibitor Concentrate (Berinert®) for the Treatment of Cutaneous Attacks of Acute Hereditary Angioedema Compared to Historical Untreated Controls

T. Machnig, J. Bernstein, T. Craig, 2013 .

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.

William H. Yang, P. Keith, J. Bernstein, 2019, The journal of allergy and clinical immunology. In practice.

Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study

T. Machnig, J. Bernstein, W. Lumry, 2019, Allergy, Asthma & Clinical Immunology.

Review of the Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate

K. Bork, W. Kreuz, G. Korger, 2012 .

[Contraception and pregnancy in hereditary angioedema].

K. Bork, M. Böckers, 2008, Deutsche medizinische Wochenschrift.

Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate.

K. Bork, J. Hardt, 2009, The American journal of medicine.

Hereditary angioedema associated with subacute cutaneous lupus erythematosus.

K. Bork, W. Gudat, 1989, Dermatologica.

Hereditary angioedema and normal C1-inhibitor activity in women

K. Bork, H. Traupe, S. Barnstedt, 2000, The Lancet.

[Hereditary angioneurotic edema. Clinical aspects and extended diagnostic and therapeutic possibilities].

K. Bork, G. Witzke, 1979, Deutsche medizinische Wochenschrift.

The European Register of Hereditary Angioedema: Experience and Preliminary Results

R. Perricone, H. Farkas, C. Bucher, 2007 .

Treatment for hereditary angioedema with normal C1‐INH and specific mutations in the F12 gene (HAE‐FXII)

K. Bork, K. Wulff, J. Hardt, 2017, Allergy.

Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation.

Britta S. Möhl, K. Bork, K. Wulff, 2021, The Journal of allergy and clinical immunology.

Genotype‐phenotype correlations in Brazilian patients with hereditary angioedema due to C1 inhibitor deficiency

S. Cichon, W. A. Silva, K. Bork, 2019, Allergy.

Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate

K. Bork, P. Staubach‐Renz, J. Hardt, 2019, Orphanet Journal of Rare Diseases.

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin

Britta S. Möhl, K. Bork, K. Wulff, 2023, Frontiers in Physiology.

Treatment of patients with hereditary angioedema with the c.988A>G (p.Lys330Glu) variant in the plasminogen gene

T. Machnig, K. Bork, K. Wulff, 2020, Orphanet Journal of Rare Diseases.

Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor

K. Bork, K. Wulff, P. Lohse, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Antihistamine-resistant angioedema in women with negative family history: estrogens and F12 gene mutations.

K. Bork, K. Wulff, P. Lohse, 2013, The American journal of medicine.

Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

Todor A Popov, T. Zuberbier, N. Papadopoulos, 2020, Allergy.

Hereditary angioedema: Educational review

K. Bork, A. Bygum, 2006 .

Helicobacter pylori Infection as a Triggering Factor of Attacks in Patients with Hereditary Angioedema

H. Farkas, G. Füst, C. Bucher, 2007 .

Acute Edema Blisters on a Skin Swelling: An Unusual Manifestation of Hereditary Angioedema.

K. Bork, J. Fabiani, 2016, Acta dermato-venereologica.

Acquired C 1 Inhibitor ( Cl-INH ) Deficiency Type 11 Replacement Therapy with C 1-INH and Analysis of Patients ' C 1-INH and Anti-Cl-INH Autoantibodies

John D Lambris, J. Lambris, J. Alsenz, 2013 .

Acquired and Hereditary Angioedema: Pathogenesis and Therapy

K. Bork, 1988 .

Interaction between $$C\bar 1$$ -INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria

K. Bork, W. Kreuz, G. Witzke, 2004, Archives of Dermatological Research.

[Ascites and suspected acute abdomen in hereditary angioedema due to C1 inhibitor deficiency].

K. Bork, V. Eckardt, M. Böckers, 1997, Deutsche medizinische Wochenschrift.

Mutation Analysis in Hereditary Angioedema Identifies Patients at Risk for Developing Acute and Life Threatening Edema

J. Oldenburg, K. Bork, W. Kreuz, 2006 .

Hereditary Angioedema due to C1 Inhibitor Deficiency

T. Biedermann, K. Bork, M. Maurer, 2019 .

Mutation Analysis of the C1 Inhibitor Gene

J. Oldenburg, K. Bork, W. Kreuz, 2005 .

[Hereditary angioneurotic edema. Clinical picture, diagnosis, patient management and drug therapy].

K. Bork, W. Kreuz, G. Witzke, 2008, Deutsche medizinische Wochenschrift.

On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema

I. Braenne, K. Bork, K. Wulff, 2018, Allergy.

Tamoxifen may cause life‐threatening angioedema attacks in patients with hereditary angioedema

K. Bork, K. Wulff, J. Hardt, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Uncommon Signs Associated with Hereditary Angioedema with Normal C1 Inhibitor.

K. Bork, J. Bosco Pesquero, A. Sevciovic Grumach, 2020, Journal of investigational allergology & clinical immunology.

Hereditary angioedema in a single family with specific mutations in both plasminogen and SERPING1 genes

A. Zibat, B. Wollnik, M. Schön, 2020, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Genetic Analysis as a Practical Tool for Diagnosis of Hereditary Angioedema With Normal C1 Inhibitor: A Case Report.

E. Castelli, V. Muglia, K. Bork, 2016, Journal of investigational allergology & clinical immunology.

Multifocal disseminated lipoatrophy secondary to intravenous corticosteroid administration in a patient with adrenal insufficiency.

K. Bork, J. Bauerschmitz, 2002, Journal of the American Academy of Dermatology.

Atypical facial porokeratosis of Mibelli

K. Bork, J. Knop, A. Enk, 1991, The British journal of dermatology.

Persistent skin ulcers, mutilations, and acro-osteolysis in hereditary sensory and autonomic neuropathy with phospholipid excretion. Report of a family.

K. Bork, M. Böckers, P. Benes, 1989, Journal of the American Academy of Dermatology.

[Multiple lymphocytoma at the point of puncture as complication of acupuncture treatment. Traumatic origin of lymphocytoma].

K. Bork, 1983, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[Psoriasis and bullous pemphigoid].

K. Bork, 1987, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Psoriasis arthropathica und Amyloidose

K. Bork, H. Holzmann, 2004, Archiv für dermatologische Forschung.

Concentration and kinetic studies of intravenous acyclovir in serum and breast milk of a patient with eczema herpeticum.

K. Bork, P. Benes, 1995, Journal of the American Academy of Dermatology.

Lichen planus: histologic involvement of an epidermoid cyst.

K. Bork, N. Hoede, 1983, Dermatologica.

Hereditary progressive mucinous histiocytosis. Immunohistochemical and ultrastructural studies in an additional family.

K. Bork, 1994, Archives of dermatology.

Germline mutation in PDGFRB may be implicated in hereditary progressive mucinous histiocytosis.

M. Simpson, J. McGrath, J. Demoulin, 2020, The British journal of dermatology.

A germline mutation in the platelet‐derived growth factor receptor beta gene may be implicated in hereditary progressive mucinous histiocytosis

M. Simpson, J. McGrath, J. Demoulin, 2021 .

Fat-storing hamartoma of dermal dendrocytes. Clinical, histologic, and ultrastructural study.

K. Bork, H. Gabbert, J. Knop, 1990, Archives of dermatology.

Prior pregnancy and melanoma survival.

K. Bork, W. Bräuninger, 1986, Archives of dermatology.

[Familial congenital hypotrichosis with "uncombable hair," retinal pigmentary dystrophy, juvenile cataract and brachymetacarpia: another entity of the ectodermal dysplasia group].

K. Bork, R. Rochels, D. Schmidt, 1987, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[Hereditary angioedema in the German-speaking region].

B. Wüthrich, R. Bauer, K. Bork, 1998, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Increased frequency of multiple primary melanomas in hereditary familial melanoma.

A. Nake, K. Bork, W. Bräuninger, 1981, Dermatologica.

25 years of safety experience with C1 inhibitor concentrate in treatment of acute hereditary angioedema attacks

K. Bork, W. Kreuz, S. Fremann, 2011 .

[Hypovolemic shock caused by ascites in hereditary angioedema].

K. Bork, 1998, Medizinische Klinik.

[Physical forces in blister formation. I. Direct measurement of blister fluid colloid osmotic pressure in suction blisters and in bullous diseases (author's transl)].

K. Bork, 1977, Archives for dermatological research = Archiv fur dermatologische Forschung.

[Skin changes in malignant diseases].

K. Bork, N. Hoede, 1983, Der Internist.

[Bromoderma tuberosum caused by anticonvulsive treatment with potassium bromide].

K. Bork, U. Grieben, J. Pfeifle, 1992, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

P. Keith, J. Bernstein, R. Schellenberg, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[Paraffin granuloma of the penis].

K. Bork, N. Hoede, W. Bräuninger, 1986, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Diseases of the Oral Mucosa and the Lips

K. Bork, W. Burgdorf, G. Korting, 1996 .

Angioedema with normal complement studies: What do we know?

K. Bork, C. Katelaris, A. Grumach, 2023, The journal of allergy and clinical immunology. In practice.